Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
This study is comparing AI-assisted Mastisting Training App with Controlled group for people with Schizophrenia Disorder. Participants receive AI-assisted Mastisting Training App or Controlled group and complete study visits and assessments.
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
This study is looking at whether a digital support tool can help people with anxiety or depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is not yet recruiting in the United States. It is testing an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment for schizophrenia.
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
This study is looking at whether The Awareness, Courage and Love Intervention can help people with depression or anxiety. Participants take part in The Awareness, Courage and Love Intervention and complete follow-up assessments.
This study is not yet recruiting in the United States. It focuses on depression.
This observational study is following people with depression or anxiety to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
This study is not yet recruiting in the United States. It is testing efficacy and Tolerability of Xanomeline/Trospium for schizophrenia.
This study is looking at care and outcomes for people with bipolarity, Organoids, or Neurodevelopmental Conditions. Taking part may give some people access to blood sample, but direct benefit is not guaranteed.